p53, guardian of the genome
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53, famously known as the ‘Guardian of the genome’ plays a key role in manifestation of cellular senescence via several different mechanisms (Lane, 1992; Kastenhuber and Lowe, 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Lane, 1992
In the citing paper
“p53 is an crucial tumor suppressor that is mutated in more than 50% of human cancers”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Lane, 1992
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893
Research works printed but not linked: 3
- Sturzbecher, H.-W. Oncogene (in the press).
- Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Cancer Res. 51, 6304–6311 (1991).
- Bischoff, F. Z. et al. Cancer Res. 50, 7979–7984 (1990).
Cited by
Items 801–900 of 1,029
Suntharalingam, K., Mendoza, Ó., Duarte, A. A., Mann, D. J., & Vilar, R. (2013) · Metallomics · doi:10.1039/c3mt20252f · Cited by 108
Hampp, S., Kießling, T., Büchle, K. E., Mansilla, S. F., Thomale, J., Rall-Scharpf, M., Ahn, J., Pospiech, H., Gottifredi, V., & Wiesmüller, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605828113 · Cited by 107
p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.
Offer, H., Zurer, I., Bánfalvi, G., Rehak, M., Falcovitz, A., Milyavsky, M., Goldfinger, N., & Rotter, V. (2001) · PubMed · Cited by 98
The potential roles for embryotrophic ligands in preimplantation embryo development
O’Neill, C. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn002 · Cited by 101
From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
Wang, Z., & Zhang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810880 · Cited by 118
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 107
Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine
Galmarini, C. M., Clarke, M. L., Falette, N., Puisieux, A., Mackey, J. R., & Dumontet, C. (2001) · International Journal of Cancer · doi:10.1002/ijc.1628 · Cited by 100
Assessing responses to cancer therapy using molecular imaging
Neves, A., & Brindle, K. M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.002 · Cited by 113
Potten, C. S., & Booth, C. E. (1997) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(97)00219-8 · Cited by 97
Daujat, S., NEEL, H., & PIETTE, J. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02369-1 · Cited by 116
Pathology, T. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96325-p · Cited by 97
Ren, Z.-P., Pontén, F., Nistér, M., & Pontén, I. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960621)69:3<174::aid-ijc4>3.0.co;2-x · Cited by 96
Emig, R., Magener, A., Ehemann, V, Meyer, A., Stilgenbauer, F., Volkmann, M., Wallwiener, D., & Sinn, H. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.739 · Cited by 97
Apoptosis: A programmed cell death involved in ovarian and uterine physiology
Vinatier, D., Dufour, P., & Subtil, D. (1996) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0301-2115(96)02467-0 · Cited by 107
Applications of amorphous track models in radiation biology
Cucinotta, F. A., Nikjoo, H., & GOODHEAD, D. T. (1999) · Radiation and Environmental Biophysics · doi:10.1007/s004110050142 · Cited by 106
Cell cycle regulatory functions of the human oncoprotein MDM2.
Deb, S. P. (2003) · PubMed · Cited by 104
Liukkonen, T., Rajala, P., Raitanen, M., Rintala, E., KAASINEN, E. S., & Lipponen, P. (1999) · European Urology · doi:10.1159/000020039 · Cited by 96
Kinsella, A. R., Smith, D. B., & Pickard, M. R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.164 · Cited by 107
“It is now known that the p53 gene product in its role as 'guardian of the genome' (Lane, 1992; Levine et al, 1993), plays an important role in determining the cellular response to DNA damage.”
BackgroundThe Molecular Epidemiology of Lung Cancer
Spivack, S. D., Fasco, M. J., Walker, V. E., & Kaminsky, L. S. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089898 · Cited by 96
Cell cycle control and cancer chemotherapy
Kohn, K. W., Jackman, J., & O'Connor, P. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540411 · Cited by 100
Pietenpol, J. A., & Vogelstein, B. (1993) · Nature · doi:10.1038/365017a0 · Cited by 96
Anil, B., Riedinger, C., Endicott, J. A., & Noble, M. E. M. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913004459 · Cited by 94
“Introduction The transcription factor p53 is the major tumour suppressor of the cell and plays a central role in the regulation of many cellular mechanisms such as apoptosis, DNA repair, angiogenesis, survival and senescence (Lane, 1992; Vogelstein et al., 2000; Fridman & Lowe, 2003).”
BackgroundBaud, M. G. J., Bauer, M. R., Verduci, L., Dingler, F. A., Patel, K. J., Horil Roy, D., Joerger, A. C., & Fersht, A. R. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.035 · Cited by 94
Enane, F. O., Saunthararajah, Y., & Korc, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0919-9 · Cited by 101
The p53 story: layers of complexity
Braithwaite, A. W., Royds, J. A., & Jackson, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi091 · Cited by 95
In defense of the somatic mutation theory of cancer
Vaux, D. L. (2011) · BioEssays · doi:10.1002/bies.201100022 · Cited by 106
Apoptosis: molecular mechanisms and implications for human disease
ORRENIUS, S. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00881.x · Cited by 99
Korkolopoulou, P., Christodoulou, P., Kouzelis, K., Hadjiyannakis, M., Priftis, A., Stamoulis, G., Seretis, A., & Thomas-Tsagli, E. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.216 · Cited by 95
Sakorafas, G. H., Tsiotou, A. G., & Tsiotos, G. G. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0144 · Cited by 103
Guo, Y., Li, Q., Zhao, G., Zhang, J., Yuan, H., Feng, T., Ou, D., Gu, R. C., Li, S., Li, K., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04208-3 · Cited by 98
Wagner, J., Ma, L., Rice, J. J., Hu, W., Levine, A. J., & Stolovitzky, G. A. (2005) · Systems Biology · doi:10.1049/ip-syb:20050025 · Cited by 100
Identification of ANKRD11 as a p53 coactivator
Neilsen, P. M., Cheney, K. M., Li, C.-W., Chen, J. D., Cawrse, J. E., Schulz, R. B., Powell, J. A., Kumar, R., & Callen, D. F. (2008) · Journal of Cell Science · doi:10.1242/jcs.026351 · Cited by 93
“The p53 protein is the most important tumor suppressor in the cell and is described as ‘the guardian of the genome’ (Lane, 1992).”
BackgroundRoles of ubiquitin signaling in transcription regulation
Hammond-Martel, I., Yu, H., & Affar, E. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.009 · Cited by 110
Levy, N., Yonish-Rouach, E., Oren, M., & Kimchi, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7942 · Cited by 94
Role of p53 in UVB-Induced Apoptosis in Human HaCaT Keratinocytes
Henseleit, U., Zhang, J., Wanner, R., Haase, I., Kolde, G., & Rosenbach, T. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12340708 · Cited by 107
p53 and IGFBP-3: Apoptosis and Cancer Protection
Grimberg, A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3008 · Cited by 105
Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro
Huschtscha, L. I., Bartier, W. A., Ross, C. E., & Tattersall, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.10 · Cited by 94
Optimized radiation therapy based on radiobiological objectives
Brahme, A. (1999) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(99)80053-8 · Cited by 94
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
Shinozaki, T., Nota, A., Taya, Y., & Okamoto, K. (2003) · Oncogene · doi:10.1038/sj.onc.1207176 · Cited by 93
“In a large number of tumor cells, deletions or inactivating mutations of the p53 gene are found (Olivier et al., 2002). p53 functions as a sensor to detect harmful alterations of the genome that might eventually cause malignant transformation of damaged cells (Lane, 1992).”
BackgroundTAp73 is required for spermatogenesis and the maintenance of male fertility
Inoue, S., Tomasini, R., Rufini, A., Elia, A. J., Agostini, M., Amelio, I., Cescon, D., Dinsdale, D., Zhou, L., Harris, I. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323416111 · Cited by 86
Zhang, H., Xu, J., Long, Y., Maimaitijiang, A., Su, Z., Li, W., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312928 · Cited by 108
“The p53 protein is often referred to as the ‘guardian of the genome’ and plays a central role in maintaining cell integrity and preventing malignant transformation [5].”
miRNA Modulation of the Cellular Stress Response
Babar, I. A., Slack, F. J., & Weidhaas, J. B. (2008) · Future Oncology · doi:10.2217/14796694.4.2.289 · Cited by 93
Isoindolinone-based inhibitors of the MDM2–p53 protein–protein interaction
Hardcastle, I. R., Ahmed, S. U., Atkins, H., Calvert, H., Curtin, N. J., Farnie, G., Golding, B. T., Griffin, R. J., Guyenne, S., Hutton, C., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.061 · Cited by 94
Jab1 Induces the Cytoplasmic Localization and Degradation of p53 in Coordination with Hdm2
Oh, W., Lee, E., Sung, Y. H., Yang, M.-R., Ghim, J., Lee, H., & Song, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601857200 · Cited by 102
Ubiquitin, E6-AP, and Their Role in p53 Inactivation
Scheffner, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00003-5 · Cited by 111
Hypoxia attenuates the p53 response to cellular damage
Achison, M., & Hupp, T. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206434 · Cited by 107
“The DNA damage or ‘guardian of the genome’ model for p53 activation was an important milestone in marking p53 as a stress-regulated transcription factor (Lane, 1992).”
BackgroundVikhanskaya, F., Vignati, S., Beccaglia, P., Ottoboni, C., Russo, P., D’Incalci, M., & Broggini, M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4018 · Cited by 106
Cerella, C., Teiten, M.-H., Radogna, F., Dicato, M. A., & Diederich, M. F. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.03.006 · Cited by 99
Effects of pH alterations on stress- and aging-induced protein phase separation
Jin, X., Zhou, M., Chen, S., Li, D., Cao, X., & Liu, B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04393-0 · Cited by 103
ISL1 Promotes Pancreatic Islet Cell Proliferation
Guo, T., Wang, W., Zhang, H., Liu, Y., Chen, P., Ma, K., & Zhou, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022387 · Cited by 93
Ullrich, S. J., Sakaguchi, K., Lees-Miller, S. P., Fiscella, M., Mercer, W. E., Anderson, C. W., & Appella, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5954 · Cited by 93
The Flavoring Agent Dihydrocoumarin Reverses Epigenetic Silencing and Inhibits Sirtuin Deacetylases
Olaharski, A. J., Rine, J., Marshall, B. L., Babiarz, J., Zhang, L., Verdin, E., & Smith, M. T. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010077 · Cited by 93
Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression
Basudhar, D., Somasundaram, V., de Oliveira, G. A., Kesarwala, A. H., Heinecke, J. L., Cheng, R. Y. S., Glynn, S. A., Ambs, S., Wink, D. A., & Ridnour, L. A. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6813 · Cited by 99
Nenoi, M., Ichimura, S., Mita, K., Yukawa, O., & Cartwright, I. L. (2001) · PubMed · Cited by 92
Galle, P. R. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80189-4 · Cited by 92
Photocarcinogenesis and Skin Cancer Prevention Strategies.
Seebode, C., Lehmann, J., & Emmert, S. (2016) · PubMed · Cited by 160
Blom, R., Guerrieri, C., Stål, O., Malmström, H., & Simonsen, E. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1997.4889 · Cited by 91
Baskar, R., Sparatore, A., Soldato, P. D., & Moore, P. K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.029 · Cited by 91
Oakley, G. G., Loberg, L. I., Yao, J., Risinger, M. A., Yunker, R. L., Zernik-Kobak, M., Khanna, K. K., Lavin, M. F., Carty, M. P., & Dixon, K. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1199 · Cited by 91
“Exposure to DNA-damaging agents triggers signal transduction pathways that are thought to play a role in activating repair and recovery processes (Fornace, 1992; Lane, 1992; Fuks et al., 1993; Herrlich and Rahmsdorf, 1994).”
Backgroundc-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
Sauter, G., Carroll, P. R., Moch, H., Kallioniemi, A. H., KERSCHMANN, R. L., Narayan, P., Mihatsch, M. J., & Waldman, F. M. (1995) · Europe PMC (PubMed Central) · Cited by 91
Murphy, K. L., Dennis, A. P., & Rosen, J. M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0128com · Cited by 92
“A p73 Western blot with a COS cell positive control (1) followed by p53 172R-H-expressing stable cells, untreated and irradiated (lanes 1 and 2, respectively) and then untreated and irradiated control cells (lanes 3 and 4, respectively).”
BackgroundHuo, T., Wang, X. W., Forgues, M., Wu, C.-G., Spillare, E. A., Giannini, C., Bréchot, C., & Harris, C. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204495 · Cited by 102
“…activity. p53-mediated apoptosis is an important event for maintaining tissue homeostasis and preventing genomic instability diseases (Lane, 1992; Prives, 1993; Lowe et Oncogene al., 1993, 1994; Symonds et al., 1994; Levine, 1997; Wang, 1997; Schwartz and Rotter, 1998; Oren, 1999).”
BackgroundRiley, D. J., Nikitin, A. Y., & Lee, W. (1996) · Nature Medicine · doi:10.1038/nm1296-1316 · Cited by 91
Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells
Trejo‐Solís, C., Escamilla-Ramírez, Á., Jiménez‐Farfán, D., Castillo‐Rodríguez, R. A., Flores‐Nájera, A., & Cruz-Salgado, A. (2021) · Pharmaceuticals · doi:10.3390/ph14090871 · Cited by 104
James, S. Y., Mercer, E., Brady, M., Binderup, L., & Colston, K. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702103 · Cited by 90
“A number of genes and proteins are implicated in the regulation of apoptosis, which include the tumour suppressor gene, p53 (Lane, 1992; Gottlieb & Oren, 1996), the caspases (Jacobson & Evan, 1994), the APO-1/Fas antigen (Cosman, 1994) and the bcl-2 family (Yang et al., 1996).”
BackgroundThe molecular basis of targeting protein kinases in cancer therapeutics
Tsai, C., & Nussinov, R. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.04.001 · Cited by 105
“mutations in approximately half of the sporadic human tumors [3], has earned its name the “cellular gatekeeper for growth and division” [4] or the “guardian of the genome” [5].”
BackgroundMutant KRAS, chromosomal instability and prognosis in colorectal cancer
Castagnola, P., & Giaretti, W. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.06.003 · Cited by 98
Notochord is essential for oligodendrocyte development inXenopus spinal cord
Maier, C. E., & Miller, R. H. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970215)47:4<393::aid-jnr4>3.0.co;2-9 · Cited by 16
p53-dependent SIRT6 expression protects Aβ42-induced DNA damage
Jung, E. S., Choi, H., Song, H., Hwang, Y. J., Kim, A., Ryu, H., & Mook-Jung, I. (2016) · Scientific Reports · doi:10.1038/srep25628 · Cited by 89
Franklin, D. A., He, Y., Leslie, P. L., Tikunov, A. P., Fenger, N., Macdonald, J. M., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep38067 · Cited by 90
“(A) Fructose-(2,6)-bisphosphate (F2,6BP) levels were determined in WT, Mdm2+/+;p53ER/− and Mdm2−/−;p53ER/− MEF cells in the presence or absence of 4-OHT after 24 h.”
BackgroundMethodInfluentialNagaich, A. K., Appella, E., & Harrington, R. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14842 · Cited by 89
A Mechanistic Analysis of Nitric Oxide-Induced Cellular Toxicity
Burney, S., Tamir, S., Gal, A., & Tannenbaum, S. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0114 · Cited by 109
Absence of p53 Mutations in Malignant Mesotheliomas
Mor, O., Yaron, P., Huszar, M., Yellin, A., Jakobovitz-Picard, O., Brok‐Simoni, F., Rechavi, G., & Reichert, N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.1.8998073 · Cited by 96
Benzo[a]pyrene Activates the Human p53 Gene through Induction of Nuclear Factor κB Activity
Pei, X., Nakanishi, Y., Takayama, K., Bai, F., & Hara, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35240 · Cited by 90
MRI Texture Analysis Predicts p53 Status in Head and Neck Squamous Cell Carcinoma
Dang, M., Lysack, J. T., Wu, T., Matthews, T. W., Chandarana, S. P., Brockton, N. T., Bose, P., Bansal, G., Cheng, H., Mitchell, J. R., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4110 · Cited by 90
Pathways of chemotherapy resistance in castration-resistant prostate cancer
Mahon, K. L., Henshall, S. M., Sutherland, R. L., & Horvath, L. G. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0343 · Cited by 100
“Activated p53 regulates the transcription of genes to cause cell cycle arrest, DNA repair and occasionally apoptosis (Lane 1992).”
BackgroundCorrea, H. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1579759 · Cited by 111
Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer
Parfenyev, S. E., Singh, A., Fedorova, O., Daks, A. A., Kulshreshtha, R., & Barlev, N. A. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03327-7 · Cited by 89
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma
Hedberg, M. L., Berry, C. T., Moshiri, A. S., Xiang, Y., Yeh, C. J., Atillasoy, C., Capell, B. C., & Seykora, J. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073478 · Cited by 107
Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression
David, D., Nair, S. A., & Pillai, M. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.11.003 · Cited by 98
Lee, J. H., Kim, S. Y., Kil, I. S., & Park, J.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700303200 · Cited by 89
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 89
Swamy, M. V., Herzog, C. R., & Rao, C. V. (2003) · PubMed · Cited by 89
Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology
Pang, L. Y., & Argyle, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.010 · Cited by 105
“involved in growth arrest, DNA repair and apoptosis in response to DNA damage [61, 62].”
BackgroundPeters, G. J., van Triest, B., Backus, H. H. J., Kuiper, C. M., van der Wilt, C. L., & Pinedo, H. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00026-5 · Cited by 100
Johnson, M. I., Robinson, M., Marsh, C., Robson, C. N., Neal, D. E., & Hamdy, F. C. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19981201)37:4<223::aid-pros3>3.0.co;2-o · Cited by 96
Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 103
How viral oncogenes make the cell cycle
Jansen‐Dürr, P. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)81455-7 · Cited by 99
Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?
Charni‐Natan, M., Aloni-Grinstein, R., Osher, E., & Rotter, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00374 · Cited by 97
Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression
Jomová, K., Alomar, S. Y., Valko, R., Fresser, L., Nepovimová, E., Kuča, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04146-5 · Cited by 130
“TP53 is a gene encoding the p53 protein, consists of six major domains, functions as a tumor suppressor, and is often described as the"Guardian of the Genome” (Lane 1992; Hernández Borrero And El-Deiry 2021).”
Effects of Matrine on proliferation and differentiation in K-562 cells
Zhang, L. P., Jiang, J., Tam, J. W. O., Zhang, Y., Liu, X.-S., Xu, X., Liu, B. Z., & He, Y. J. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00145-4 · Cited by 88
Adenovirus-mediated p53 Gene Therapy for Human Gliomas
Lang, F. F., Yung, W. K. A., Sawaya, R. A., & Tofilon, P. J. (1999) · Neurosurgery · doi:10.1097/00006123-199911000-00016 · Cited by 95
Development and translational imaging of a TP53 porcine tumorigenesis model
Sieren, J. C., Meyerholz, D. K., Wang, X., Davis, B. T., Newell, J. D., Hammond, E., Rohret, J. A., Rohret, F., Struzynski, J. T., Goeken, J. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75447 · Cited by 91
“In response to various cellular stresses, such as DNA damage or oncogene activation, the p53 protein becomes stabilized and transactivates genes that induce growth arrest or apoptotic cell death (11, 26).”
BackgroundShi, X., Zhao, Y., Jiao, Y., Shi, T., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064266 · Cited by 87
Prediction of Disordered RNA, DNA, and Protein Binding Regions Using DisoRDPbind
Peng, Z., Wang, C., Uversky, V. N., & Kurgan, L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6406-2_14 · Cited by 93
p53 and the Viral Connection: Back into the Future ‡
Aloni-Grinstein, R., Charni‐Natan, M., Solomon, H., & Rotter, V. (2018) · Cancers · doi:10.3390/cancers10060178 · Cited by 90
Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours
Haugen, B. R., Woodmansee, W. W., & McDermott, M. T. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01500.x · Cited by 87
“…used in many clinical pathology laboratories, making this potential marker less likely to be widely used in the near future. p53 The p53 tumour suppressor gene encodes the p53 protein, which is a unique transcription factor with important antiproliferative effects on cells (Lane, 1992; Marx, 1993).”
BackgroundRepairable–Conditionally Repairable Damage Model Based on Dual Poisson Processes
Lind, B. K., Persson, L. M., Edgren, M., Hedlöf, I., & Brahme, A. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)160[0366:rrdmbo]2.0.co;2 · Cited by 92
“Apoptosis is the cell’s way of handling fatal damage that according to the damage surveillance system of the cell cannot be handled directly by the repair system so that ATM, TP53 and other proteins (36) assist in triggering apoptosis rather than conserving a severely damaged site or mutation.”
BackgroundApoptosis: molecular mechanisms and implications for cancer chemotherapy.
Gugelaar, H. J., Vermes, A., Vermes, I., & Haanen, C. (1997) · Pharmacy World & Science · doi:10.1023/a:1008646229977 · Cited by 86
Apoptosis in normal and cancer stem cells
Iannolo, G., Conticello, C., Memeo, L., & Maria, R. D. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.004 · Cited by 106
Metadata
- Authors
- Lane, D. P.
- Affiliations
- University of Dundee (GB)
- Corresponding author
- Lane, D. P.
- ORCID
- Lane, D. P.
- Venue
- Nature
- Published
- 1992-07
- Volume
- 358
- Issue
- 6381
- Pages
- 15-16
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012053348
- Cited by
- 5,138
- References
- 19
- Citations by year
- 2026: 84 · 2025: 92 · 2024: 122 · 2023: 112 · 2022: 135 · 2021: 142 · 2020: 150 · 2019: 128 · 2018: 140 · 2017: 138 · 2016: 142 · 2015: 135 · 2014: 150 · 2013: 142 · 2012: 143
- FWCI
- 97.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- TP53, p53, TP53 mutation, cancer, genome stability, tumor suppressor
- MeSH terms
- Animals, Chromosome Mapping, DNA Damage, DNA Repair, DNA-Binding Proteins, Gene Expression Regulation, Humans, Oncogenes, Transcription Factors, Genes, Tumor Suppressor, Tumor Suppressor Protein p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.